BERIN O'NEILL: Open Payments
NPI 1295477578 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,757 in 26 payments from 6 companies in 2025. Trend: 2023 $152 · 2024 $552 · 2025 $2,757
Food & beverage: $1,507Consulting: $1,125Education: $100Travel & lodging: $25
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $2,274 |
| GENZYME CORPORATION | 1 | $145 |
| Novartis Pharmaceuticals Corporation | 1 | $132 |
| Incyte Corporation | 1 | $127 |
| PFIZER INC. | 2 | $41 |
| UCB, Inc. | 1 | $39 |
Products named: TREMFYA, DUPIXENT, Opzelura, CIBINQO, Bimzelx.
Industry payments across IL — which companies pay providers there.
